Clearbridge Investments, LLC Care Dx, Inc. Transaction History

Clearbridge Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $123,260 - $202,543	7,675 Added 0.46%	1,664,147 $28.3 Million
Q2 2022 Aug 11, 2022	BUY	$20.49 - $39.72 $61,019 - $118,286	2,978 Added 0.18%	1,656,472 $35.6 Million
Q1 2022 May 13, 2022	BUY	$28.19 - $46.6 $332,190 - $549,134	11,784 Added 0.72%	1,653,494 $61.2 Million
Q4 2021 Feb 11, 2022	SELL	$41.2 - $73.6 $143,128 - $255,686	-3,474 Reduced 0.21%	1,641,710 $74.7 Million
Q3 2021 Nov 12, 2021	SELL	$59.15 - $91.99 $495,381 - $770,416	-8,375 Reduced 0.51%	1,645,184 $104 Million
Q2 2021 Aug 13, 2021	BUY	$63.02 - $95.11 $9.15 Million - $13.8 Million	145,175 Added 9.62%	1,653,559 $151 Million
Q1 2021 May 13, 2021	BUY	$57.62 - $95.6 $24.8 Million - $41.1 Million	430,407 Added 39.93%	1,508,384 $103 Million
Q4 2020 Feb 10, 2021	BUY	$41.43 - $77.09 $18.3 Million - $34.1 Million	442,692 Added 69.68%	1,077,977 $78.1 Million
Q3 2020 Nov 12, 2020	BUY	$30.88 - $37.94 $19.6 Million - $24.1 Million	635,285 New	635,285 $24.1 Million

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.26B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.